StockData
AtriCure, Inc. logo

AtriCure, Inc. (ATRC) stock

ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30893% above fair value
$55.02−0.29 (-0.52%)

Close on Nov 17, 2026Market cap $2.80BP/E 262.0Yield –

AtriCure price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

AtriCure's price to sales ratio was 5.1× on Nov 11, 2026, against 3.5× a year earlier. Over the last 5 years it ranged from 2.5× to 12.3×, with a median of 4.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.1×+1.3
2025Dec 31, 20253.8×+0.5
2024Dec 31, 20243.3×−1.1
2023Dec 29, 20234.4×−2.1
2022Dec 30, 20226.5×−5.8
2021Dec 31, 202112.3×+0.4
2020Dec 31, 202011.9×+6.1
2019Dec 31, 20195.8×+0.2
2018Dec 31, 20185.6×+1.9
2017Dec 29, 20173.7×−0.6
2016Dec 30, 20164.3×−0.8
2015Dec 31, 20155.2×−0.3
2014Dec 31, 20145.5×+0.5
2013Dec 31, 20135.0×+3.3
2012Dec 31, 20121.7×−1.1
2011Dec 30, 20112.8×–

More AtriCure figures

See a number that looks wrong?